EBAC
NASDAQ:EBACU
European Biotech Acquisition Corp.
- Stock
Last Close
11.71
02/03 21:00
Market Cap
183.50M
Beta: -
Volume Today
77.64K
Avg: 1.53K
PE Ratio
40.74
PFCF: −356.46
Dec '21 | Dec '22 | ||
|---|---|---|---|
net income | 1.48M - | 342.89K 76.81% | |
depreciation and amortization | |||
deferred income tax | |||
stock based compensation | |||
change in working capital | 386.01K - | 2.30M 496.66% | |
accounts receivables | |||
inventory | |||
accounts payables | 57.91K - | 301.63K 420.91% | |
other working capital | 328.10K - | 2.00M 510.03% | |
other non cash items | -2.55M - | -3.16M 23.78% | |
net cash provided by operating activities | -688.83K - | -514.79K 25.27% | |
investments in property plant and equipment | |||
acquisitions net | |||
purchases of investments | |||
sales maturities of investments | |||
other investing activites | -127.55M - | ||
net cash used for investing activites | -127.55M - | ||
debt repayment | -37.81K - | ||
common stock issued | 132.10M - | ||
common stock repurchased | |||
dividends paid | |||
other financing activites | -2.96M - | -45K 98.48% | |
net cash used provided by financing activities | 129.10M - | -45K 100.03% | |
effect of forex changes on cash | |||
net change in cash | 868.28K - | -559.79K 164.47% | |
cash at beginning of period | 868.28K - | ||
cash at end of period | 868.28K - | 308.49K 64.47% | |
operating cash flow | -688.83K - | -514.79K 25.27% | |
capital expenditure | |||
free cash flow | -688.83K - | -514.79K 25.27% |
All numbers in USD (except ratios and percentages)